OTCMNEPTF
Market cap0kUSD
Dec 19, Last price
0.00USD
1D
0.00%
1Q
-99.99%
Name
Neptune Wellness Solutions Inc
Chart & Performance
P/E
—
P/S
0.00
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
39.11%
Rev. gr., 5y
9.51%
Revenues
53m
-13.75%
Net income
-82m
L-12.82%
CFO
-39m
L-43.18%
Earnings
Feb 14, 2025
Profile
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑02 | 2015‑02 | |
| Income | |||||||||
Revenues | 52,615 -13.75% | 61,007 37.12% | |||||||
Cost of revenue | 74,939 | 72,685 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (22,323) | (11,678) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | (38,306) | (11,818) | |||||||
Tax Rate | |||||||||
NOPAT | 15,983 | 140 | |||||||
Net income | (81,712) -12.82% | (93,730) -39.45% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 10,224 | 6,235 | |||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 7,878 | 642 | |||||||
Long-term debt | 19,788 | 17,268 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 3,400 | (14,563) | |||||||
Net debt | 25,655 | 6,976 | |||||||
| Cash flow | |||||||||
Cash from operating activities | (38,607) | (67,944) | |||||||
CAPEX | (1,258) | (2,424) | |||||||
Cash from investing activities | 3,190 | (2,910) | |||||||
Cash from financing activities | 26,073 | 7,442 | |||||||
FCF | 50,752 | 21,036 | |||||||
| Balance | |||||||||
Cash | 2,011 | 10,934 | |||||||
Long term investments | |||||||||
Excess cash | 7,883 | ||||||||
Stockholders' equity | 21,316 | (2,607) | |||||||
Invested Capital | (2,228) | 70,301 | |||||||
ROIC | 46.96% | 0.20% | |||||||
ROCE | 1,002.00% | ||||||||
| EV | |||||||||
Common stock shares outstanding | 295 | 121 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | (18,637) | (4,077) | |||||||
EV/EBITDA | |||||||||
Interest | 2,203 | 2,672 | |||||||
Interest/NOPBT | |||||||||